We have also shown that although aldometanib does not possess cytotoxicity toward cancerous or normal cells, it robustly induces tumor cells to undergo apoptosis and necroptosis, signs of tumoricidal activity, and this effect depends on infiltration of the cytotoxic lymphocytes CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.